folic acid has been researched along with Blast Crisis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bois, P; Chatelier, A; Clarhaut, J; Cronier, L; Fraineau, S; Guilhot, F; Guilhot, J; Monvoisin, A; Papot, S; Peraudeau, E; Randriamalala, E; Renoux, B; Thomas, M; Tranoy-Opalinski, I | 1 |
| Bertino, JR; Elisseyeff, Y; Flintoff, WF; Goker, E; Gorlick, R; Mazumdar, M; Steinherz, P; Trippett, T | 1 |
2 other study(ies) available for folic acid and Blast Crisis
| Article | Year |
|---|---|
A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; beta-Galactosidase; Blast Crisis; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Doxorubicin; Drug Delivery Systems; Female; Folate Receptor 1; Folate Receptor 2; Folic Acid; HEK293 Cells; HL-60 Cells; Humans; Leukemia, Myeloid; Male; Middle Aged; Neoplastic Stem Cells; Young Adult | 2013 |
Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression.
Topics: Adolescent; Adult; Aged; Biological Transport; Blast Crisis; Carrier Proteins; Child; Child, Preschool; Drug Resistance; Fluoresceins; Folic Acid; Humans; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reduced Folate Carrier Protein | 1997 |